Clinical features and neurological outcomes in pediatric immune-mediated thrombotic thrombocytopenic purpura: A report from a large pediatric hematology center.
Sara GraciaaSegun AdeagboGrace FongMargo RollinsPatricia McElfreshPatricia E ZerraCarolyn M BennettCassandra D JosephsonMichael BrionesRoss M FasanoSatheesh ChonatPublished in: Pediatric blood & cancer (2022)
Children and adolescents recovering from iTTP are at high risk for neurocognitive deficits from initial and possibly ongoing microvascular disease. Due to risk for long-term neurological deficits, we recommend neuropsychological testing in addition to monitoring of other organ functions in all children with TTP, as well as long-term surveillance of ADAMTS13 activity during remission to detect and promptly treat early relapse.